Abstract:289 Objectives Phosphodiesterase 10A (PDE10A) is a potential therapeutic target for neurological diseases with striatal pathology, including Parkinson disease, Huntington disease and schizophrenia. PET radiotracers for PDE10A have been developed for in vivo assessing the PDE10A level and for target engagement for relevant therapeutic interventions. The aim of this study is to in vivo compare two potent and selective PDE10A radiotracers, [11C]TZ1964B and [18F]MNI659, in quantifying the expression of PDE10A in non-human primate (NHP) brain. Methods [11C]TZ1964B and [18F]MNI659 were used for double scans in the same NHP (totally 4 scans in 2 adult male cynomolgus monkeys, weighing 7-8 kg). The microPET was performed using a Focus 220 scanner, with an injection dose of ~10 mCi for each tracer. Binding potential (BP) of striatum was calculated to assess the radiotracer uptake using reference-based modeling (Logan Reference (LoganREF) model and simplified reference tissue model (SRTM)), with cerebellum as the reference. The striatum-to-cerebellum ratio of regional area under the time tissue-activity curve (AUC) was also calculated as a modeling-independent parameter for evaluating tracer uptake. HPLC metabolite analysis of NHP plasma was also performed for both the tracers. Results Both radiotracers showed high accumulation in NHP striatum. Striatal uptake of [11C]TZ1964B reached the max SUV value around 35 min post-injection (p.i.), while the peak of [18F]MNI659 appeared at ~10 min p.i.. Compared to [18F]MNI659, the tracer clearance of [11C]TZ1964B in the striatum was slower, probably due to differences in in vivo tracer metabolism. However, the washout in other (non-target) brain regions was similarly fast, indicating the target specificity and regional selectivity for both two tracers. The BP estimates of [11C]TZ1964B were 3.72 by LoganREF and 4.39 by SRTM; the values for [18F]MNI659 were 5.08 by BP-LoganREF and 5.33 by BP-SRTM. AUC ratios of these two tracers were 5.87 for [11C]TZ1964B and 7.60 for [18F]MNI659. Based on the BP-LoganREF and BP-SRTM data in NHP striatum, coefficients of variation were ~10% for [11C]TZ1964B and ~30% for [18F]MNI659. Additionally, the in vivo tracer metabolism study showed, at 60 min p.i., the percentage of parent compounds were ~70% for [11C]TZ1964B and ~50% for [18F]MNI659. Conclusions Both [11C]TZ1964B and [18F]MNI659 could serve as suitable PET radiotracers for assessment of PDE10A in the brain, regardless of differences in in vivo tracer characteristics. Due to the half-life of radiotracers, the C-11 tracer could be utilized for multiple injections for patients in the same day, while the F-18 tracer have commercial distribution advantage that allows delivery to multiple sites with 3-4 hrs drive distance. Further studies will compare these two tracers in human subjects. Research support: NIH/NIMH #MH092797 and NIH/NINDS #NS075527, #NS061025. References: 1. Barret, et al. Journal of Nuclear Medicine, 2014, 55:1297-1304; 2. Liu, et al. NeuroImage, 2015, 121:253-262.

[~(11)C]MP4A PET Imaging of Acetylcholinesterase in Brain of the Transgenic Mice and Rhesus Monkey

The Distribution of[~(11)C]MP4A-a PET Imaging Agent for Brain Acetylcholinesterase Activity in Rat

The Preparation of [~11c] MP4A, a PET Imaging Agent for Brain Acetylcholinesterase Activity

Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys

Imaging Mitochondrial Complex I Activation During a Vibrotactile Stimulation: A PET Study Using [18F]BCPP-EF in the Conscious Monkey Brain

Characterization of a Novel M4 PAM PET Radioligand [11C]PF06885190 in Nonhuman Primates (NHP)

Investigation of Purification and Identification on N-[11C] Methylpiperidin-4-yl Acetate As PET Imaging Agent of Brain Acetylcholinesterase Activity

[~(11)C]6-OH-BTA-1's Biodistribution In Vivo Distribution of APP Transgenic Mice and Healthy Rhesus Monkey

PET Imaging of Neutrophils Infiltration in Alzheimer's Disease Transgenic Mice

Pet Imaging For Dynamically Monitoring Neuroinflammation In App/Ps1 Mouse Model Using [F-18]Dpa714

Radiosynthesis and evaluation of acetamidobenzoxazolone based radioligand [C-11]N '-MPB for visualization of 18 kDa TSPO in brain

Molecular imaging in neuroscience research with small-animal PET in rodents.

Multi-target PET evaluation in APP/PS1/tau mouse model of Alzheimer’s disease

PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [18F]DPA714

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

Molecular Imaging in Neuroscience Research with Small-Animal PET in Rodents

PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain

Comparison of Two Pde10a Radiotracers, [11c]tz1964b and [18f]mni659 in the Brains of Non-Human Primates

Preclinical evaluation of a microtubule PET ligand [11C]MPC-6827 in tau and amyotrophic lateral sclerosis animal models

In Vivo Characterization of Two 18F-Labeled PDE10A PET Radioligands in Nonhuman Primate Brains.

A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissues